港股上市公司雍禾医疗（02279）今日盘中大跌5.24%，引发市场关注。这家植发行业龙头企业近期面临营收下滑、门店收缩等多重挑战，其经营状况与行业高速增长形成鲜明对比。
根据最新财报，雍禾医疗2025年上半年营业收入为8.62亿元，同比下降4.29%。虽然公司净利润从去年同期的亏损1.39亿元转为盈利2791万元，但这主要是通过大幅压缩成本费用实现的。公司销售费用从4.63亿元降至3.81亿元，管理费用从1.41亿元降至1.12亿元，研发费用更是被削减了27%。
值得注意的是，雍禾医疗正面临门店扩张停滞和人才流失的双重压力。截至2025年6月，公司植发机构数量从75家减少至63家，专业医疗团队人数也从1612人降至1401人，其中医生数量降幅超过30%。与此同时，公司两大核心业务均陷入"量增价减"或"量价双杀"困境，植发业务客单价下降14.03%，医疗养固业务消费者人数和客单价双双下滑。这种依赖关店压缩费用的经营策略虽然短期内美化了财务报表，但可能损害公司的长期发展潜力，引发了投资者对其未来盈利能力的担忧。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.